Medical devices, healthcare technology and the business of care
PMA approval · P230040

Cordella Pulmonary Artery Sensor System (CorPASS)

Endotronix, Inc. · Decision date Jun 20, 2024

MEDTECHLEDGER EXPLANATIONP230040

What did the FDA approve?

Endotronix, Inc. received an original PMA approval (P230040) on 2024-06-20 for the Cordella Pulmonary Artery Sensor System, an implantable hemodynamic device under product code MOM. The source statement describes the system as intended to measure, record and transmit pulmonary artery pressure data from NYHA Class III heart failure patients at home on diuretics and guideline-directed medical therapy who have been stable for 30 days on GDMT. The stated output purpose is to aid clinicians in assessment and management of heart failure, with the goal of reducing heart failure hospitalizations.

No supplement type or reason is recorded, so the supplied record identifies this as an original PMA rather than a change to an earlier approval; the identifier does not establish a parent PMA. The statement reports an intended purpose and a stated goal, not independent evidence of safety or clinical effectiveness, and the record supplies no performance or trial data. Class III status, diuretic use, GDMT stability of 30 days, and the hospitalization-reduction goal are the stated scope boundaries.

FDA approval order statement

The Cordella Pulmonary Artery Sensor System is intended to measure, record and transmit pulmonary artery pressure (PAP) data from NYHA Class III heart failure patients who are at home on diuretics and guideline-directed medical therapy (GDMT) as well as have been stable for 30 days on GDMT. The device output is meant to aid clinicians in the assessment and management of heart failure, with the goal of reducing heart failure hospitalizations.
Regulatory pathway
Original PMA
Clinical specialty
Cardiovascular
Decision date
Jun 20, 2024

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P230040
Regulatory pathway
Premarket approval application
Product code
MOM
Decision code
APPR
Decision date
Jun 20, 2024
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: System, hemodynamic, implantable.

Product code
MOM
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P230040 received

    Application receipt date recorded by FDA.

  2. P230040 · FDA decision

    APPR

  3. P230040/S033 · Related supplement

    Cordella Pulmonary Artery Sensor System (CorPASS)

  4. P230040/S034 · Related supplement

    Cordella Pulmonary Artery Sensor System (CorPASS)

  5. P230040/S031 · Related supplement

    Cordelia Pulmonary Artery Pressure Sensor System (CorPASS)

  6. P230040/S035 · Related supplement

    Cordella Pulmonary Artery Sensor System (CorPASS)

  7. P230040/S030 · Related supplement

    Cordella Pulmonary Artery Sensor System

Timeline entries are records held by MedtechLedger for P230040. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P230040

Product / regulatory recordCompanyPathwayDecision dateSource
Endotronix, Inc.PMA supplementSep 25, 2026FDA
Endotronix, Inc.PMA supplementOct 14, 2026FDA
Endotronix, Inc.PMA supplementOct 16, 2026FDA
Endotronix, Inc.PMA supplementOct 20, 2026FDA
Endotronix, Inc.PMA supplementOct 29, 2026FDA

Explore the linked device profile

Other records with product code MOM

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Endotronix, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
1415 W. Diehl Rd., Suite 500w, Naperville, IL, 60563

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records